SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

10 Feb 2023 Evaluate
The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 341.16 millions.The Company's Net profit for the December 2022 quarter have declined marginally to Rs. 37.60  millions as against Rs. 37.78 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 64.95 millions from 71.36 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 341.16 326.41 4.52 1007.36 926.91 8.68 1154.45 1101.46 4.81
Other Income 6.29 8.27 -23.94 21.16 13.82 53.11 17.20 7.54 128.12
PBIDT 64.95 71.36 -8.98 194.94 199.58 -2.32 252.74 203.35 24.29
Interest 6.82 4.93 38.34 20.65 8.37 146.71 14.01 10.64 31.67
PBDT 58.13 66.43 -12.49 174.29 191.21 -8.85 238.73 192.71 23.88
Depreciation 16.01 15.67 2.17 47.43 42.47 11.68 57.71 25.20 129.01
PBT 42.12 50.76 -17.02 126.86 148.74 -14.71 181.02 167.51 8.07
TAX 4.52 12.98 -65.18 17.29 27.23 -36.50 31.97 42.65 -25.04
Deferred Tax -3.32 -2.54 30.71 -8.95 -7.19 24.48 -7.80 1.19 -755.46
PAT 37.60 37.78 -0.48 109.57 121.51 -9.83 149.05 124.86 19.37
Equity 126.51 122.17 3.55 126.51 122.17 3.55 122.17 122.17 0.00
PBIDTM(%) 19.04 21.86 -12.92 19.35 21.53 -10.13 21.89 18.46 18.58

Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×